Testimonials From The Pharmaceutical Out-licensing Course

This has been a really useful and informative course! I also highly valued the examples of situations from David’s personal experience.

UCL Business PLC

Christina Panaretou, Senior Business Analyst - United Kingdom - May 2017
High quality, well-considered content. Time was well managed to get the most out of the two days. Excellent.

Alfacyte

Gillian Brown, CEO - United Kingdom - May 2017
Attending this course gives you a good plan on how to approach out-licensing. You can gain a lot in this course by training on examples and learning from the pitfall experiences of David.

AOP Orphan Pharmaceuticals

Johannes Pilz, Business Development Manager - Austria - May 2017
Overall a very good experience, highly relevant content and backed up by a very experienced and personable speaker.

Oxford Pharmascience

Chris Hill, Chief Financial Officer - United Kingdom - October 2016
For those who are interested in extending their basic knowledge of out-licensing, business negotiations, risk assessment and decision making, C.E.L.forpharma’s “The Pharmaceutical Out-licensing Course” is the best option you can find. Experienced lecturer with wide knowledge in the industry and friendly atmosphere will help you to absorb maximum benefits from the course. Especially recommended for junior-middle specialists.

BIOCAD

Dmitry Pasechnik, Head of overseas commercial strategy - Russia - October 2016
For someone who is new to Pharmaceutical Out-licensing, this course is a must and provides an excellent foundation covering all the elements which are important. David Scott is a very experienced and pragmatic global expert in licensing and business development. His anecdotes and real live examples made the theory very clear and easy to follow. I very much enjoyed the two day course and interactions.

Michael Frizberg, - Switzerland - October 2016
David’s course sets a solid framework to pharmaceutical licensing. His lectures are backed up by many personal experiences, which makes it all very relevant. It was an all-rounded course, and great enjoyment to participate in!

Alghanim Healthcare

Nadine Zouk, Business Development & QA Manager - Kuwait - October 2016
This course is top quality thanks to the pharma expert, David Scott, and C.E.L.forpharma’s organisation. The program is complete and easily covered in 2 days.

Legacy Healthcare

Angelo Mello, Director Business Development & Licensing - Switzerland - April 2016
This course provided a great overview of the out-licensing process. David was an excellent instructor and prepared us for all possible scenarios.

Cetylite Industries

Anthony Moreira, Business Development Manager - United States - April 2016
David Scott’s course covers all aspects of pharmaceutical out-licensing, and you can meet like-minded people while on the course. I highly recommend it!

Wockhardt

Prafulla Kirdant, Business Development & Licensing Executive - United Kingdom - April 2016
David Scott's pharma out-licensing course was a great experience in a warm atmosphere!

Cinfa Biotech

Dieter Braun, Director Business Development - Germany - April 2015
David clearly is an expert in this field, and as a real expert, he knows how to make things clear and easily understandable. I feel like I have my work programme for the coming months!

Aelis Pharma

Valerie Scappaticci, President - France - November 2014
The best out-licensing course! A lot of information provided and well structured.

AJA Pharma

Faisal Dail, Deputy General Manager - Saudi Arabia - June 2014
This course was recommended to me by the CEO of Poxel and it was indeed a brilliant course! Thanks!

Poxel

Daniel Cravo, Medchem & Patent Manager - France - October 2013
I already attended the business development and valuation courses and again, I am very satisfied. The out-licensing course was perfect on all dimensions: expert, course content, organization and audience. I rated this course top level on all parameters - congratulations!

Mitotech Pharma

Natalia Perekhvatova, Director - UK - October 2013
Well prepared, perfectly tailored course, valuable for an innovative professional audience and biotech.

Temapharm

Michal Szymanowski, Business Development Manager - Poland - March 2013
David provided a very well structured overview of the licensing process. Also the interactions and discussions between the participants made this a very interesting and joyful training.

PROVAXS

Sven Arnouts, Business Developer - Belgium - March 2013
Very clear presentation. Speakers with many years of experience (like David Scott) are highly valuable to course participants.

Venture Valuation

Paul Kochman, Support Biotechgate and independent valuations - Switzerland - October 2012
David Scott has a lot of expertise, being able to deliver it clearly to an audience that is quite differentiated (nationalities, realities, backgrounds).

Merck Serono

Sergio Hernandez, Director Business Development - Mexico - October 2012
I would recommend to any BD executive to get this knowledge before (!) starting a serious deal.

AVVA

Valeriy Tupolev, Head of Business Development - Russia - October 2012
Very thorough breakdown of the out-license procedure, great company, convenient location, and I left feeling very satisfied.

GW Pharmaceuticals

James Brodie, Business Development Scientist - UK - April 2012
David Scott gave a good overview of the entire licensing process. It was great to be able to discuss questions / issues with someone who has so much knowledge in the area and so much experience from previous deals in several areas.

Accelerator

Maria Fors, CEO - Sweden - April 2012
The Pharmaceutical Out-licensing Course is a very interesting course. A definite to do for those who want to gain out-licensing deals.

Sandoz

Olivia Ceulemans, Business Development Manager - Belgium - April 2012
I am fully satisfied as I got the overview of the out-licensing process by attending this course with David Scott.

Pierre Fabre

Olivia Gulli, Jurist - France - November 2011
David Scott's pharmaceutical out-licensing course is really good. David has a calm presentation style and uses very good examples to illustrate the theory. I would have loved a 3rd day with more case studies.

Nycomed

Amalia Graf-Czikajlo, Senior International Commercial Project Manager - Switzerland - June 2011
This training was perfect! David Scott shared a huge amount of experience and expertise in these 2 days.

Roche

Andrey Chusov, Business Development Manager - Russia - June 2011
Very good basic course, with lots of practical “nuts and bolts” material. David Scott’s presentation style has a good pacing, offers plenty of time for questions and he uses real life examples. Not much to improve on!

Galderma

Bill Carson, Head of Integration Office - USA - June 2011
David Scott did a really good job teaching/benchmarking the fundamentals of licensing. The course was intensive and I enjoyed the vivid discussions during the presentations and the coffee breaks. The course gave a perfect opportunity for networking.

ALK-Abello

Ulla Seppala, Manager - Denmark - June 2011
C.E.L.forpharma's pharmaceutical out-licensing course provided a thorough overview of all steps in the out-licensing process. It helped me to structure my practical experience and enriched my knowledge with international practices in out-licensing activities. For the newcomers this course with David Scott is a very useful and unique source of theoretical information, real life examples and problem-solving solutions. The exchange of participant experiences during coffee breaks is invaluable too.

Novartis

Elena Govorova, Business Development Manager - Russia - November 2010
Excellent coverage of the subject matter; all goals given in the program description were fully met! David Scott offers a well structured course at the right level of detail. There are many valuable insights to gain from an experienced licensing professional and great instructor. Discussions with peers were also very useful. In sum, this course can be recommended not only to novices to the licensing field.

Biotest AG

Heidrun Geissler-Schuetter, Director International Business Development - Germany - November 2010
After following this course for two days, one has in-depth understanding of the out-licensing process, the tools needed as well as the challenges and rewards that come along in the out-licensing process. David Scott explains, illustrates and brings across profound knowledge and enthusiasm about this subject. If you are involved in out-licensing, do this course!

Orphan Europe

Ralph Blom, New Markets Manager - France - November 2010